使用ddPCR优化血液恶性病和败血症的临床指标:一项回顾性研究
Bei Zheng1,2,3, Chuanwei Xin1,2,3, Yizhuo Liu4
1Department of Pharmacy, Tongde Hospital of Zhejiang Province Affiliated to Zhejiang Chinese Medical University (Tongde Hospital of Zhejiang Province), Hangzhou, 310012, Zhejiang, China.
Infectious diseases and therapy
|August 29, 2025
概括
滴滴数字PCR (ddPCR) 显著改善了血液恶性病患者的败血症诊断,提供更快的结果和更好的结果. 这种快速检测有助于优化抗菌治疗并减少死亡率.
科学领域:
- 传染性疾病
- 分子诊断
- 血液学
背景情况:
- 早期抗菌治疗对于患有血性恶性瘤 (HM) 的患者至关重要.
- 滴滴数字PCR (ddPCR) 可以快速检测病原体和抗菌素耐药性 (AMR) 基因.
- 在患有血症的HM患者中,ddPCR的临床效用仍在研究中.
研究的目的:
- 系统地评估ddPCR在HM患者的败血症诊断中的作用.
- 评估ddPCR对临床结果和抗菌药物管理的影响.
- 将ddPCR性能与传统血液培养 (BC) 进行比较.
主要方法:
- 这项研究涉及到2023年1月至2025年3月期间的400名血栓炎患者.
- 与BC (150名患者) 结合的ddPCR与单独的BC (250名患者) 的比较.
- 使用倾向分数匹配 (PSM),子组和敏感性分析来评估结果,包括28天死亡率和抗生素使用密度 (AUD).
主要成果:
- 与BC相比,ddPCR显示出更高的阳性率 (49. 33%,而不是17. 50%) 和显著更快的周转时间 (4. 06小时而不是72. 47小时).
- ddPCR组显示28天死亡率降低 (HR=0. 55),临床反应率改善,炎症标志物下降更大.
- 通过ddPCR指导的抗菌优化导致疗效提高 (85. 11%) 和AUD降低 (OR=-28. 93).
结论:
- 在HM有败血症患者的诊断效率方面,ddPCR显著超过BC.
- ddPCR加速了病原体和AMR基因的识别,从而优化了抗菌治疗和改善了临床结果.
- 这项研究支持在免疫抑制群体中实施ddPCR治疗败血症.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
1.2K
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
769
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
769